The living donor and recipient of a recently flawed kidney transplant at UPMC are a couple who did not know that the donor, a woman, was hepatitis C positive, and didn't find out until after the kidney was transplanted into the man, sources told the Pittsburgh Post-Gazette.

The woman was tested for hepatitis C prior to surgery, and the results showed she was positive for the virus, but the two people on the transplant team who should have checked the results and stopped the transplant, failed to do so, sources also said.

On May 11, two days after the transplant became public, a board member said Elizabeth Concordia, UPMC's executive vice president, gave a 20-minute presentation to the hospital system's board of directors during its regular meeting and told them that the positive test was missed during 12 steps throughout the process.

The failure to act on the positive test was so serious that it was considered a "systemic" problem in the way the protocols failed in this one case, Ms. Concordia said, according to the board member, and that's why UPMC voluntarily shut down its living donor transplant program May 6. The program will remain closed until an investigation is completed and new protocols can be drawn up to prevent the error from occurring again.

Advertise with us

The hospital system would not confirm these details or release a copy of its internal protocols that would show who on the transplant team should have reviewed the test results.

Because of the current federal, state, county and internal investigations, "I don't think it's appropriate for us to say right now what the protocols are," said UPMC spokeswoman Jennifer Yates. "But we are reviewing everything to ensure it is not a systemic problem" beyond this one case.

Ms. Yates said UPMC has done 975 living donor kidney transplants since 1988 and this is the only known case of a hepatitis C positive donor kidney being transplanted into someone who was hepatitis C negative.

The error was discovered by UPMC, which self-reported it to the Centers for Medicare and Medicaid Services (CMS), and it was not related to a review by CMS that was "coincidentally" ongoing at the time of the discovery at Children's Hospital of Pittsburgh of UPMC, a CMS spokeswoman said.

Despite the way it occurred, UPMC will probably not be found in violation of any federal guidelines for the failure of the transplant team to review the positive hepatitis C test.

Advertise with us

That's because while current guidelines from the United Network for Organ Sharing, the organization that oversees the nation's transplant centers and could suspend or shut a program down for deficiencies, do cover deceased donor transplants, they do not specifically cover living donor transplants, except in a limited way.

Emily Blumberg, an infectious disease specialist at the University of Pennsylvania, said that it is because live donations are still a relatively new medical advancement compared to cadaver donations.

"What has happened is that live donations in the United States have really taken off in the last decade, and there's only been a push to standardize live donation processes recently," said Dr. Blumberg.

One of the factors driving the push to finally address guidelines for living donor transplants is the rapid emergence of so-called paired kidney donation networks. In the networks, a willing living donor, who isn't a match to a friend or relative who needs a kidney, gives their kidney to someone else in the network. That recipient then has a friend or relative give a kidney to someone else, and so on.

Over the last five years, the rise of such networks have allowed hundreds of people to get kidney transplants from people they previously did not know, including a chain involving 32 donors and recipients -- 16 of whom got new kidneys -- that UPMC was part of earlier this year.

Advertise with us

"Everybody is [testing for viruses] but it would be helpful if we could all be doing it the same way -- especially with paired donation networks," said Dr. Blumberg, who also chairs UNOS's disease transmission advisory committee.

Through that committee, UNOS is now beginning to craft new guidelines that are specific to live donation transplants. A conference in July in Baltimore that Dr. Blumberg is helping to organize will act as a public forum on the proposed new guidelines that will address everything from which viruses should be tested for, to which tests should be used, to how the results are communicated and other issues.

The guidelines that do exist now don't spell out how information about a test is to be conveyed and confirmed by people on the transplant team, which are protocols that are left to each individual hospital to establish.

Those same guidelines -- which were written for the more common deceased donor transplants -- also don't explicitly require testing of living donor organs for viruses like hepatitis C, though, as a rule, transplant centers like UPMC do so anyway.

"I can tell you every transplant center in the country already screens donors for things like hepatitis C or other infections that would affect our use of that organ," Dr. Blumberg said.

Advertise with us

The Centers for Disease Control and Prevention, which help design guidelines that CMS uses to review transplant programs, also is in the process of updating its guidelines to better address living donor transplants.

Currently the Organ Procurement and Transplantation Network, which UNOS operates for the federal government by contract, "has policies on hepatitis C screening for deceased donors which includes use of antibody testing, but there are no specific policies for living donor screening," Matthew Kuehnert, director of the CDC's office of blood, organ and other tissue safety, said in a statement. "Policies on informed consent concerning transplant recipients are in place, but these policies primarily relate to the offer of organ donations."

The current guidelines for prevention of HIV transmission in transplants "are in the process of revision to include donor screening and recipient follow up for HIV, hepatitis B, and hepatitis C, and a draft will be published in the Federal Register for public comment in the next few weeks," Dr. Kuehnert said.

Still, CMS officials said in a generic case where some hospital had a positive test for a virus but failed to check it and ended up transplanting an organ anyway, there are several existing guidelines that would be at issue, including whether the donor and recipient received proper informed consent information, and whether UPMC provided proper patient and living donor management.

For example, CMS's guidelines for Informed Consent for Transplant Patients requires hospitals to tell the patients before the surgery about "the risk of contracting HIV, hepatitis B virus, hepatitis C virus, cancer or malaria if the donor is infected, but the infection is not detectable at the time of donation."

Advertise with us

The guidelines further require that "the discussion of risks should include any issues that could affect the success of the organ transplant (the condition of the organ) and any issues that could potentially place the health of the patient at risk."

Typically, if CMS found UPMC violated any guidelines in the case, it would give the hospital system time to correct the mistakes. If it did not correct the mistakes quickly enough, CMS could pull the hospital's Medicare funding.

Although UPMC has told patients that it expects its living donor program to open within weeks, experts say CMS and UNOS investigations could take months.